Get the Stockscreener App
3.32
5.68%
-0.20
Protagenic Therapeutics Inc stock is traded at $3.32, with a volume of 61,629.
It is down -5.68% in the last 24 hours and down -5.41% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$3.52
Open:
$3.5
24h Volume:
61,629
Relative Volume:
0.03
Market Cap:
$3.14M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-2.887
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
-8.29%
1M Performance:
-5.41%
6M Performance:
-52.09%
1Y Performance:
-74.42%
1-Day Range:
$3.30
$3.50
1-Week Range:
$3.30
$3.75
52-Week Range:
$2.35
$15.82
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
3.32 | 3.14M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm - MSN
Protagenic & Phytanix Merge in All-Stock Move, Sparking Retail Frenzy - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSETXNM), Servotronics, Inc. (NYSE AmericanSVT), Protagenic Therapeutics, Inc. (Nasdaq – - TradingView
Wall Street Zen Upgrades Protagenic Therapeutics (NASDAQ:PTIX) to “Sell” - Defense World
Protagenic Therapeutics raises $3.1 million from warrants By Investing.com - Investing.com Canada
Protagenic Therapeutics swaps warrants for shares - Investing.com Australia
Is Protagenic Therapeutics Inc (NASDAQ: PTIX) Still Trending? - Stocksregister
Protagenic Therapeutics Receives $3.1 Million from Recent Warran - GuruFocus
Protagenic Therapeutics (PTIX) Raises $3.1M Through Warrant Acti - GuruFocus
Protagenic Therapeutics Raises $3.1 Million From Warrants - marketscreener.com
Protagenic Therapeutics Secures $3.1M for Drug Development - TipRanks
Protagenic Therapeutics (PTIX) Raises $3.1M Through Warrant Activities | PTIX Stock News - GuruFocus
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity | PTIX Stock News - GuruFocus
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity - ACCESS Newswire
Protagenic Therapeutics and Phytanix merge in all stock deal - The Pharma Letter
Fresh $3.1M Funding Boosts Protagenic Therapeutics CNS Drug Pipeline After Major Merger - Stock Titan
Nasdaq Top 5 Premarket Gainers - MSN
Top Medical Stocks To Consider – May 19th - Defense World
Pharmaceutical Stocks To Follow Today – May 19th - Defense World
Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish - MSN
Protagenic Therapeutics swaps warrants for shares By Investing.com - Investing.com Nigeria
Protagenic Therapeutics Issues Common Stock for Warrants - TipRanks
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic surges on all-stock merger deal with Phytanix - FirstWord Pharma
Protagenic Therapeutics merges with Phytanix Bio in all-stock deal By Investing.com - Investing.com South Africa
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TXNM, SVT, INZY, PTIX on Behalf of Shareholders - The Malaysian Reserve
Protagenic Therapeutics (PTIX) Stock Soars 240% On Phytanix Merger - Benzinga
Protagenic Therapeutics, Phytanix Bio enter business combination agreement - TipRanks
PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders - The Joplin Globe
Protagenic and Phytanix merger prompts a stock surge - BioWorld MedTech
Dow Tumbles 200 Points; ZIM Integrated Shipping Services Posts Upbeat Earnings - Benzinga
Protagenic Therapeutics stock soars on merger to create Neuroactive Biopharmaceutical company By Investing.com - Investing.com South Africa
Protagenic Therapeutics stock soars on merger to create Neuroactive Biopharmaceutical company - Investing.com Canada
Protagenic Therapeutics Skyrockets on Merger with Phytanix Bio: A Biotech Powerhouse in the Making? - RagingBull
Protagenic Therapeutics Completes Acquisition of Phytanix Bio - TipRanks
Protagenic Therapeutics, Phytanix Bio to combine in all-stock transaction - TipRanks
Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews
Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2SEC Filing - marketscreener.com
Protagenic Therapeutics (PTIX) Announces Merger with Phytanix Bio | PTIX Stock News - GuruFocus
Protagenic Therapeutics merges with Phytanix Bio in all-stock deal - Investing.com
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic - GuruFocus
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders - FinancialContent
PTIX Merges with Phytanix Bio in All-Stock Deal | PTIX Stock New - GuruFocus
Why Quantum Computing Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics, Inc.\new SEC 10-Q Report - TradingView
Pre-market Movers: CNSP, XLO, PLRZ, SGMO... - RTTNews
Performance Tech stock hits 52-week low at $0.4 - MSN
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.91%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):